CompletedPhase 1NCT01704521

Viral Kinetics in HCV Clearance in Subjects With Hemophilia

Studying Congenital factor XI deficiency

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Kenneth Sherman
Principal Investigator: Kenneth E Sherman, MD, PhD
University of Cincinnati
Intervention: PegInterferon(drug)
Enrollment: 5 enrolled
Eligibility: 18 years · All sexes
Timeline: 2012 – 2014

Study locations (1)

UC Physicians Company, Cincinnati, Ohio, United States

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Vertex Pharmaceuticals Incorporated · Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01704521 on ClinicalTrials.gov

← Back to all trials